ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Australia Online Tailored Testosterone Replacement Therapy For Low T: Update

TRT Australia (15 671 760 848) has announced that it is accepting new patients for its online testosterone replacement therapy treatments.

-- TRT Australia has announced new openings for consultations for its telehealth testosterone replacement therapy programmes, which are designed for men suffering from a testosterone deficiency. Individuals experiencing unexplained fatigue, muscle loss, and abrupt mood changes are encouraged to book a phone consultation with the clinic.

For more information, please visit https://trtaustralia.com/free-consultation/

Despite being associated with ageing, low testosterone, also known as male hypogonadism, can affect men in any age group, with some research suggesting that around 6% of all males are impacted. The condition can disrupt sexual function, mood, energy levels, muscle mass, and bone health, along with other bodily functions, significantly impairing quality of life.

However, health experts say that if a hormone imbalance is diagnosed, it can be corrected with testosterone replacement therapy (TRT). This treatment is legal in Australia and is offered by specialised hormone therapy clinics such as TRT Australia, but it is heavily regulated, and patients must both present with symptoms and speak to a licensed healthcare professional before beginning treatment.

With TRT Australia, prospective patients are required to have blood test results from within the past four months to determine their eligibility. If the patient has not recently conducted a blood test, they may either request one from their GP or book a private test through TRT Australia’s network of doctors. The latter is the clinic’s recommended option, as the test will be carried out with low testosterone in mind, testing for specific markers such as kidney and liver function, lipid profile, and glucose levels, in addition to free and total testosterone levels—markers that general blood tests may miss.

Once the patient has sent their blood work to TRT Australia, one of the clinic’s healthcare professionals will review the results within 24 hours before contacting the patient to discuss their options. If the physician determines that the client’s symptoms are caused by low T and can be corrected with TRT, they develop a personalised treatment plan with a form of testosterone medication that is best suited for the patient depending on their medical history and preferences.

TRT Australia’s TRT programmes can be carried out completely online, and medications will be delivered directly to the patient’s address by a partnered pharmacy.

More information is available at https://trtaustralia.com/

Contact Info:
Name: James Malachowski
Email: Send Email
Organization: TRT Australia
Address: 7–11 The Avenue, Hurstville, NSW 2220, Australia
Website: https://trtaustralia.com/X

Source: PressCable

Release ID: 89187276

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  237.41
-0.97 (-0.41%)
AAPL  259.30
-1.18 (-0.45%)
AMD  245.66
+0.62 (0.25%)
BAC  52.06
-0.48 (-0.91%)
GOOG  314.78
-0.94 (-0.30%)
META  628.61
-1.25 (-0.20%)
MSFT  372.21
+1.34 (0.36%)
NVDA  186.07
-2.56 (-1.36%)
ORCL  139.79
+1.70 (1.23%)
TSLA  349.38
+0.43 (0.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.